Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02494141 · ClinicalTrials.gov registry record · Phase 4
Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD
A Phase 4 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
NCT02494141 is a Phase 4 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 68 participants.
The verdict
NCT02494141, a Phase 4 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
Study Summary
The proposed research will determine the effectiveness of curcumin for improving the health and function of arteries in children and young adults with autosomal dominant polycystic kidney disease (ADPKD). The study also will provide insight into how curcumin improves artery health by determining the physiological mechanisms (biological reasons) involved and offer exploratory evidence if curcumin can slow kidney growth. This will be done by comparing these measurements in children and young adults who are randomized to receive either curcumin or placebo for 1 year.
Interventions
- OTHER Placebo
- DRUG Curcumin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2015-11-12 |
| Est. Completion | 2021-02-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02494141
The ClinicalTrials.gov registry entry for NCT02494141 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02494141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02494141 about?
NCT02494141 is a clinical study titled "Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD". The proposed research will determine the effectiveness of curcumin for improving the health and function of arteries in children and young adults with autosomal dominant polycystic kidney disease (ADPKD). The study also will provide insight into how curcumin improves artery health by determining the...
What is the current status of trial NCT02494141?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2015-11-12. Estimated completion is 2021-02-01.
What interventions are being tested in trial NCT02494141?
The interventions under investigation include: Placebo (OTHER), Curcumin (DRUG).
Who is sponsoring clinical trial NCT02494141?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.